Immutable evidence record · ticker

MoonLake Immunotherapeutics (MLTX)

Published as observed on 15 August 2026 at 18:28 BST.

MoonLake Immunotherapeutics has a balanced company news read. Its latest completed weekly trend is positive.

As of
15 Aug 2026, 18:28
Scope
company and instrument
Evidence
12 items
Independent sources
4
Country
United States
Sector
Healthcare
Previous read
53.000
Change
-3.000

Verification

Evidence links

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, MoonLake Immunotherapeutics (MLTX), 2026-08-15, https://sharemaestro.com/evidence/07bd9ddd-c0b2-4bd6-939f-61b749bcea85/
Record checksum c5765dc3a177040a1fabe4ac7e451e0a18ed8d5189f07f563a91c31b0c02f7e4

Evidence context